首页> 外文学位 >Mechanisms of T cell tolerance to the RNA-binding nuclear autoantigen human La/SS-B.
【24h】

Mechanisms of T cell tolerance to the RNA-binding nuclear autoantigen human La/SS-B.

机译:T细胞对RNA结合核自身抗原人La / SS-B的耐受机制。

获取原文
获取原文并翻译 | 示例

摘要

Cellular mechanisms of T cell tolerance to nuclear antigens, especially those that bind RNA, are unclear. Presented here is the first T Cell Receptor (TCR)/neo-self antigen (Ag) double transgenic (Tg) mouse model to investigate CD4+ T cell tolerance to a ubiquitous nuclear ribonucleoprotein. We hypothesized that thymic tolerance to the ubiquitously expressed, human La (hLa)/Sjogren's Syndrome (SS)-B autoantigen occurs and is influenced by antigen presentation.;We generated T cell hybridomas specific for the immunodominant hLa epitope 61-84 and determined that they expressed TCRs with similar characteristics. Individual human CD2 promoter-driven constructs of the alpha and beta chains from one of these TCRs, designated 3B5.8, were coinjected to generate a hLa-specific TCR transgenic mouse. Essentially all (98-99%) peripheral CD4 + T cells from 3B5.8 TCR (Valpha8.4/Vbeta10 I-Ek-restricted TCR) Tg mice were Vbeta10+. Tg Vbeta10 cell surface expression levels were physiologically indistinguishable from that of non-Tg mice. 3B5.8 T cells responded specifically to stimulation with recombinant hLa and hLa61-84 peptide but not recombinant mouse La. Positive selection occurred and was equivalent in 3B5.8 Tg mice of H-2k/k and H-2k/b haplotypes but was not observed in the presence of H-2b/b. Thymic deletion of CD4+CD8-(CD4SP) Vbeta10 + cells occurred in 3B5.8/hLa double Tg, H-2k/k mice but was incomplete in H-2k/b mice. Both Vbeta10+CD25 +Foxp3- and Vbeta10+CD25+Foxp3 + CD4SP thymocyte numbers were increased in 3B5.8/hLa double 16 Tg, H-2k/b mice and developed exclusively in the presence of self hLa Ag in the absence of endogenous TCRalpha. Strikingly, the relative abundance of these two populations was reversed in the periphery compared to thymus, with the Foxp3- population dominating in the thymus. Development of Vbeta10+CD25+Foxp3- and Vbeta10+CD25+Foxp3+ CD4SP thymocytes was associated with less efficient presentation of hLa by H-2k/b APC and maintenance of serologic tolerance to hLa. The thymic Vbeta10 +CD25+Foxp3- CD4SP population was identified as a viable Treg precursor as evidenced by an Annexin Vlow PI- phenotype and upregulated expression of GITR, CD44, and CD69.;These studies identify thymic deletion and CD25+Foxp3 + natural regulatory T cell (Treg) development as important mechanisms of CD4+ T cell tolerance to an RNA-binding nuclear autoantigen and demonstrate an avidity threshold that precludes Ag-specific Treg development.
机译:T细胞对核抗原,尤其是与RNA结合的抗原的耐受性的细胞机制尚不清楚。这里介绍的是第一个T细胞受体(TCR)/新自我抗原(Ag)双转基因(Tg)小鼠模型,用于研究CD4 + T细胞对普遍存在的核糖核蛋白的耐受性。我们假设发生了对普遍表达的人La(hLa)/ Sjogren综合征(SS)-B自身抗原的胸腺嘧啶耐受,并受抗原呈递的影响;;我们生成了针对免疫优势hLa表位特异性的T细胞杂交瘤,并确定他们表达了具有相似特征的TCR。来自这些TCR之一的被命名为3B5.8的单个人CD2启动子驱动的α和β链的构建体被共注射以产生hLa特异性TCR转基因小鼠。基本上,来自3B5.8 TCR(Valpha8.4 / Vbeta10 I-Ek限制性TCR)Tg小鼠的所有外周CD4 + T细胞(98-99%)都是Vbeta10 +。 Tg Vbeta10细胞表面表达水平与非Tg小鼠在生理上没有区别。 3B5.8 T细胞对重组hLa和hLa61-84肽刺激具有特异性反应,但对重组小鼠La没有反应。在H-2k / k和H-2k / b单倍型的3B5.8 Tg小鼠中出现阳性选择,并且等效。在H-2b / b存在下未观察到。 CD4 + CD8-(CD4SP)Vbeta10 +细胞胸腺缺失发生在3B5.8 / hLa双Tg,H-2k / k小鼠中,但在H-2k / b小鼠中不完全。在3B5.8 / hLa双16 Tg,H-2k / b小鼠中,Vbeta10 + CD25 + Foxp3-和Vbeta10 + CD25 + Foxp3 + CD4SP胸腺细胞数量均增加,并且仅在存在内源性自身hLa Ag的情况下发育TCRalpha。令人惊讶的是,与胸腺相比,这两个种群的相对丰度在外围发生了逆转,其中Foxp3种群在胸腺中占主导地位。 Vbeta10 + CD25 + Foxp3-和Vbeta10 + CD25 + Foxp3 + CD4SP胸腺细胞的发育与H-2k / b APC对hLa的低效呈递和维持对hLa的血清学耐受性有关。胸腺Vbeta10 + CD25 + Foxp3- CD4SP群体被鉴定为可行的Treg前体,如膜联蛋白Vlow PI型和GITR,CD44和CD69的表达上调所证明的;这些研究确定了胸腺缺失和CD25 + Foxp3 +自然调节T细胞(Treg)发育是CD4 + T细胞对RNA结合核自身抗原的耐受性的重要机制,并显示出抗原特异性阈值,从而排除了Ag特异性Treg的发育。

著录项

  • 作者

    Yaciuk, Jane Cherie.;

  • 作者单位

    The University of Oklahoma Health Sciences Center.;

  • 授予单位 The University of Oklahoma Health Sciences Center.;
  • 学科 Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 141 p.
  • 总页数 141
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号